FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Glenmark Life Sciences IPO and Paytm IPO.
Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Paytm IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Glenmark Life Sciences IPO | Paytm IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Bofa Securities India Limited Bob Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Goldman Sachs (India) Securities Private Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited |
Axis Capital Limited Citigroup Global Markets India Private Limited Goldman Sachs (India) Securities Private Limited Hdfc Bank Limited ICICI Securities Limited J.P. Morgan India Private Limited Morgan Stanley India Company Pvt Ltd |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Paytm IPO is up to ₹18,300.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Paytm IPO is ₹2,150.00 per share.
Glenmark Life Sciences IPO | Paytm IPO | |
---|---|---|
Face Value | ₹2 per share | ₹1 per share |
Issue Price (Lower) | ₹695.00 per share | ₹2,080.00 per share |
Issue Price (Upper) | ₹720.00 per share | ₹2,150.00 per share |
Issue Price (Final) | ₹720.00 per share | ₹2,150.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 20 shares | 6 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹1,060.00 Cr | up to ₹8,300.00 Cr |
OFS Issue Size | 63,00,000 shares | |
OFS Issue Size (Amount) | up to ₹453.60 Cr | up to ₹10,000.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹1,513.60 Cr | up to ₹18,300.00 Cr |
Glenmark Life Sciences IPO opens on Jul 27, 2021, while Paytm IPO opens on Nov 08, 2021. The closing date of Glenmark Life Sciences IPO and Paytm IPO is Jul 29, 2021, and Nov 10, 2021, respectively.
Glenmark Life Sciences IPO | Paytm IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jul 27, 2021 | Nov 08, 2021 |
Issue Close | Jul 29, 2021 | Nov 10, 2021 |
Basis Of Allotment (Tentative) | Aug 03, 2021 | Nov 15, 2021 |
Initiation of Refunds (Tentative) | Aug 04, 2021 | Nov 16, 2021 |
Credit of Share (Tentative) | Aug 05, 2021 | Nov 17, 2021 |
Listing date (Tentative) | Aug 06, 2021 | Nov 18, 2021 |
Anchor Lockin End date 1 | Sep 02, 2021 | Dec 15, 2021 |
Anchor Lockin End date 2 | Nov 01, 2021 | Feb 13, 2022 |
Glenmark Life Sciences IPO P/E ratio is , as compared to Paytm IPO P/E ratio of .
Glenmark Life Sciences IPO | Paytm IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 82.84% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Paytm IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 2,63,94,231 shares in Paytm IPO.
Glenmark Life Sciences IPO | Paytm IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 42,42,379 shares | 2,63,94,231 shares |
NII | 32,32,770 shares | 1,31,97,115 shares |
RII | 75,43,130 shares | 87,98,076 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,50,18,279 shares | 4,83,89,422 shares |
Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Paytm IPO subscribed 1.89x.
Glenmark Life Sciences IPO | Paytm IPO | |
---|---|---|
QIB (times) | 36.97x | 2.79x |
NII (times) | 122.54x | 0.24x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 14.63x | 1.66x |
Employee (times) | ||
Other (times) | ||
Total (times) | 44.17x | 1.89x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|